Ratings Moves: IMOS...
Health Care: Drugs
Theravance Inc. (THRX: NASDAQ)
$37.01 -2.58 | -6.50%
05/20/13 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 369,931 | 280,217 | 316,217 | 301,707 | 327,687 | 284,141 | 284,141 |
| Shares Bought | 820,446 | 300,019 | 336,019 | 321,509 | 668,373 | 632,373 | 632,373 |
| Shares Sold | 450,515 | 19,802 | 19,802 | 19,802 | 340,686 | 348,232 | 348,232 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 89.01M | 86.99M | 86.97M | 87.91M | 88.89M | 88.52M | 88.24M |
| Shares Bought | 14.84M | 13.87M | 13.87M | 13.89M | 18.60M | 18.80M | 18.74M |
| Shares Sold | 3.24M | 3.27M | 3.09M | 3.13M | 5.32M | 5.32M | 5.32M |
Portfolios with THRX
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ProSeth Klarman - Baupost Group
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Usernew
Latest THRX Headlines from TheStreet
- 3 Stocks Pushing The Drugs Industry Higher 04.15.13 | 01:04 pm
- 5 Stocks Poised to Pop on Bullish Earnings 02.11.13 | 12:02 pm
- Insiders Trading THRX KSS TUES ELGX 11.06.12 | 10:11 am
- Theravance And Merck Sign Cardiovascular Disease Collaboration 10.16.12 | 08:10 am
- Theravance And Alfa Wassermann Enter Into Agreement To Develop And Commercialize Velusetrag For Gastroparesis 10.02.12 | 04:10 pm
- GSK And Theravance Announce FDA Acceptance Of FF/VI New Drug Application (NDA) Submission In The US For COPD 09.26.12 | 04:09 am
- Theravance's Management Presents At INC At Morgan Stanley Healthcare Conference (Transcript) 09.12.12 | 02:09 pm
- Theravance To Present At The Morgan Stanley Global Healthcare Conference 08.29.12 | 04:08 pm
- GSK And Theravance Announce Completion Of The Phase III Programme For Once-Daily LAMA/LABA (UMEC/VI) In COPD 08.24.12 | 07:08 am
- Theravance Inc. Stock Downgraded (THRX) 08.02.12 | 05:08 am
Press Releases for THRX
- FDA Advisory Committee Recommends Approval Of BREOâ¿¢ ELLIPTAâ¿¢ For The Treatment Of COPD - PR Newswire 04.17.13 | 05:04 pm
Partner Headlines for THRX
- Morning Market Movers - Benzinga 04.15.13 | 09:04 am
- Pipeline Progress at Theravance - Analyst Blog - Zacks 12.05.12 | 09:12 am
- Glaxo Invests in Nigeria - Analyst Blog - Zacks 11.28.12 | 09:11 am
- For NovaBay, Simplicity Is The Father Of Invention - Seeking Alpha 11.12.12 | 09:11 am
- Loss at THRX Narrower Than Expected - Analyst Blog - Zacks 10.31.12 | 09:10 am
- Glaxo Aims to Expand Synflorix Label - Analyst Blog - NASDAQ 09.19.12 | 03:09 pm
- Glaxo Increases Stake in RGDX - Analyst Blog - NASDAQ 09.18.12 | 09:09 pm
- 5 Pharmaceutical Companies With EMA Catalysts During The Next 3 - 12 Months - Part II - Seeking Alpha 09.02.12 | 08:09 am
- Pipeline Advances at Glaxo/THRX - Analyst Blog - NASDAQ 08.27.12 | 08:08 pm
- Weekly CFO Sells Highlight: SWN, BECN, NSIT, HOLX, QLTI, THRX - GuruFocus 08.13.12 | 08:08 pm
